Tech Company Financing Transactions
Click Therapeutics Funding Round
Click Therapeutics secured a $50 million Series D funding round on 4/9/2026. Backers included Boehringer Ingelheim Venture Fund.
Transaction Overview
Company Name
Announced On
4/9/2026
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series D
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
101 Ave. of the Americas 8th Floor
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Website
Email Address
Overview
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/9/2026: Flashpass venture capital transaction
Next: 4/9/2026: Beehive Industries venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








